Neuro-ophthalmology (JAG, BKC, MAB), Massachusetts Eye and Ear, Boston, Massachusetts; Neurology (BKC), Massachusetts General Hospital, Boston, Massachusetts; Ophthalmology and Neuro-Ophthalmology (ALG), Kaiser Permanente Vallejo Medical Center, Vallejo, California; and Neuro-Ophthalmology (MAB), Beth Israel Deaconess Medical Center, Boston, Massachusetts.
J Neuroophthalmol. 2023 Dec 1;43(4):491-498. doi: 10.1097/WNO.0000000000001822. Epub 2023 Mar 2.
Parainfectious optic neuritis is an inflammatory reaction that occurs shortly after an infection without direct invasion by a pathogen. The clinical profile depends on the infectious organism. Cases of SARS-CoV-2 parainfectious optic neuritis have been reported in the literature, but there are no reviews that have applied strict inclusion criteria to more definitively establish the clinical profile associated with SARS-CoV-2.
We present 3 new cases of SARS-CoV-2 parainfectious optic neuritis. We also review the literature for definite cases by selecting only those with unambiguous clinical features and MRI findings of optic neuritis, positive SARS-CoV-2 polymerase chain reaction or serology, and the absence of myelin oligodendrocyte-glycoprotein or aquaporin-4 antibodies or other diseases associated with optic neuritis.
We report 2 cases of monophasic, unilateral SARS-CoV-2 parainfectious optic neuritis with optic disc edema and nadir visual acuities of finger counting. We report 1 case of mild SARS-CoV-2 parainfectious optic neuritis that featured cotton wool spots, peripapillary wrinkles and hemorrhages, and recurrence after an initial steroid taper. We identified 6 cases of unambiguous SARS-CoV-2 parainfectious optic neuritis from the literature. Combining our case series with the case reports in the literature, the average age was 42.8 years, 3/9 had bilateral disease, 6/8 had optic disc edema, 8/9 had nadir visual acuity of finger counting or worse, and all recovered visual acuity to 20/40 or better after therapy with steroids.
SARS-CoV-2 parainfectious optic neuritis has a clinical profile that is atypical for idiopathic optic neuritis but fairly typical of parainfectious forms of optic neuritis with a severely reduced nadir visual acuity, high likelihood of bilaterality, high incidence of optic disc edema, and prompt and significant response to corticosteroids. Further study with long-term follow-up and epidemiologic investigation will be needed to further characterize this clinical entity.
副感染性视神经炎是一种炎症反应,发生在感染后不久,没有病原体的直接侵袭。临床特征取决于感染源。文献中已有 SARS-CoV-2 副感染性视神经炎的病例报告,但尚无应用严格纳入标准更明确地确定与 SARS-CoV-2 相关的临床特征的综述。
我们报告了 3 例新的 SARS-CoV-2 副感染性视神经炎病例。我们还通过仅选择那些具有明确临床特征和视神经炎 MRI 表现、SARS-CoV-2 聚合酶链反应或血清学阳性、缺乏髓鞘少突胶质细胞糖蛋白或水通道蛋白-4 抗体或其他与视神经炎相关的疾病的明确病例,对文献进行了综述。
我们报告了 2 例单相单侧 SARS-CoV-2 副感染性视神经炎,伴有视盘水肿和视力最低值为指数。我们报告了 1 例轻度 SARS-CoV-2 副感染性视神经炎,表现为棉絮斑、视盘周围皱纹和出血,以及初始类固醇减量后的复发。我们从文献中确定了 6 例明确的 SARS-CoV-2 副感染性视神经炎病例。将我们的病例系列与文献中的病例报告相结合,平均年龄为 42.8 岁,3/9 例为双侧疾病,6/8 例有视盘水肿,8/9 例视力最低值为指数或更差,所有患者在类固醇治疗后视力均恢复至 20/40 或更好。
SARS-CoV-2 副感染性视神经炎的临床特征与特发性视神经炎不同,但与副感染性视神经炎的形式相当典型,具有严重降低的视力最低值、双侧疾病的高可能性、高视盘水肿发生率以及对皮质类固醇的迅速和显著反应。需要进一步进行长期随访和流行病学调查的研究,以进一步确定这一临床实体。